Brain tumor treatments — and outcomes — are related to the type of tumor, the location of the tumor within the nervous system, and other factors.
Existing
brain tumor treatments are often toxic, threatening neurological function and quality of life.
«Transplant drug could boost power of
brain tumor treatments, study finds.»
«It establishes a whole new approach to
brain tumor treatment,» Folkman says.
For more information about
brain tumor treatment at Moores Cancer Center at UC San Diego Health, visit: http://www.cancer.ucsd.edu/care-centers/brain-tumor/Pages/default.aspx
Mountain View, CA About Blog Comprehensive up - to - date coverage for
brain tumor treatment, aggregated from news sources all over the world by Google News.
Canine
Brain Tumor Treatment and Brain Tumor MRI Research Program The PVM Canine Brain Tumor Research Program is a research program involving all aspects of canine brain tumor research: diagnosis using MRI, surgery, chemotherapy and other post-operative therapies.
Mountain View, CA About Blog Comprehensive up - to - date coverage for
brain tumor treatment, aggregated from news sources all over the world by Google News.
Not exact matches
In 2009 he had been diagnosed with a type of rapidly growing
brain tumor called a high - grade astrocytoma that, despite aggressive
treatment, eventually evolved into a glioblastoma — the highly malignant
brain tumor that also took the lives of Vice President Joe Biden's son, Beau, in 2015 and former Sen. Ted Kennedy in 2009.
Dear Abby: My wife of 30 years is suffering from a
brain tumor and the effects of
treatment.
Given the results of a a new study reported in the British medical journal, The Lancet4 that children and young adults scanned multiple times by CT have a small increased risk of leukemia and
brain tumors in the decade following their first scan, parents should make sure a CT scan is really necessary in
treatment of their child after head injury.
Former President Jimmy Carter said that his most recent
brain scan showed no signs of cancer, more than three months after he began
treatment for four melanoma
tumors.
disclosed he is undergoing
treatment for a
brain tumor.
Model of
tumor growth in a rat
brain before radiation
treatment (left) and after one session of radiotherapy (right).
They discovered edelfosine, which has been FDA - approved as an investigational leukemia
treatment, and has also been used in clinical research for primary
brain tumors.
«Although radiosurgery has been shown to be an effective post-surgical
treatment for metastatic
brain tumors, previous studies did not compare patient outcomes from a single hospital over the same period of time,» said N. Scott Litofsky, M.D., chief of the Division of Neurological Surgery at the MU School of Medicine and senior author of the study.
Although there have been great advances made in the
treatment of leukemias and other cancers, little is known about how Glioblastomas are formed and how these
tumors infiltrate the
brain tissue.
«Trojan horse»
treatment could beat
brain tumors.»
The findings support further development of the drug as a novel
treatment for
brain tumors.
The activity of four transcription factors — proteins that regulate the expression of other genes — appears to distinguish the small proportion of glioblastoma cells responsible for the aggressiveness and
treatment resistance of the deadly
brain tumor.
Glioblastoma, the most common
brain tumor in adults, has no effective long - term
treatment and on average, patients live for 12 to 15 months after diagnosis, according to the National Cancer Institute.
While there have been improvements in the current standard
treatments, patients with glioblastoma (GBM), the most common and aggressive form of
brain tumor, still suffer from a median survival rate of only 14.6 months and 5 - year overall survival rates of less than 10 %.
That could have important implications for patient outcomes, as early diagnosis of
brain tumors enables prompt
treatment and a wider range of surgical options.
«Though many challenges still remain, such work could potentially transform
treatment outcomes for patients with glioblastoma and related
brain tumors, for which current therapies provide limited benefits.»
Treatment with an investigational CAR T - cell therapy induced complete remission of a
brain metastasis of the difficult - to - treat
tumor diffuse large - B - cell lymphoma (DLBCL), which had become resistant to chemotherapy — the first report of a response to CAR T - cells in a central nervous system lymphoma.
Glioblastoma is the most aggressive type of
tumor that originates in the
brain and with no curative
treatments currently available, the average survival time for patients ranges from 15 to 18 months.
Cancers that can have a high risk of infertility, depending on the
treatment, are certain leukemias, Hodgkin's disease,
brain tumors and bone cancer.
«Drug could limit spread of deadly
brain tumors: Study shows PPF could help treat glioblastomas by sensitizing
tumors to chemotherapy, radiation
treatments.»
«Additional studies are needed to see if these nanoparticles could also effectively deliver other antitumor genes for the
treatment of
brain tumors as well as systemic cancers.»
Another is that the transplanted bits of
tumor act nothing like cancers in actual human
brains, Fine and colleagues reported in 2006: Real - life glioblastomas grow and spread and resist
treatment because they contain what are called
tumor stem cells, but
tumor stem cells don't grow well in the lab, so they don't get transplanted into those mouse
brains.
«
Treatment as it stands now is not based on the molecular abnormalities that drive
brain tumor formation,» Miller said.
This study included 68 childhood cancer survivors who had received cranial irradiation, intrathecal chemotherapy or both for
treatment of acute lymphoblastic leukemia (ALL) or
brain tumors.
This is critical if we are to develop new
treatments to prevent epilepsy from developing after a head injury, stroke, or
brain tumor.»
Whole
brain radiotherapy (WBRT) significantly improves
tumor control in the
brain after SRS, yet because of its association with cognitive decline, its role in the
treatment of patients with
brain metastases remains controversial.
On the safety side, the panelists delved into the possible risks of injecting genetically modified cells into patients, including the potential for deadly viral infections,
brain toxicity, and, paradoxically, the growth of new
tumors brought about by CAR - T cells years after
treatment.
«Biology of childhood
brain tumor subtypes offers clues to precision
treatments: Researchers reveal differences among gene fusions in low - grade pediatric
brain tumors.»
That may be great if you are using carbon nanotubes to deliver chemotherapy drugs to people with
brain tumors, as cancer researchers in California (at City of Hope, a cancer research and
treatment center in Duarte in collaboration with NASA's Jet Propulsion Laboratory in Pasadena), hope to do.
The memory and thinking problems experienced by cancer survivors, known as «chemo
brain» or «chemo fog,» are not just the result of chemotherapy
treatment, they may start as
tumors form and develop, suggests a Baycrest - led study.
While neither a drug that targets HER3 nor one that interferes with the interaction between HER2 and HER3 were able to slow the growth of
brain metastases, combined
treatment with both an anti-HER2 and an anti-HER3 drug significantly slowed
tumor growth.
They found that the defect is highly sensitive to an existing FDA - approved drug used to treat ovarian cancer — a discovery that challenges current practice for
treatment of
brain tumors and other cancers with the same genetic defect, said the scientists.
Treatment of
brain tumors is particularly challenging because regulatory T - cells accumulate in
brain tumors and suppress an immune attack.
Their promising results do not mean that the
treatment can already be as effective in
brain tumor patients.
Current
treatments for both primary
brain tumors and
brain metastases (cancer that has spread to the
brain from another place in the body) are low in number and short on effectiveness.
Chemotherapy Alone as Initial
Treatment for Primary CNS Lymphoma in Patients Older Than 60 Years: A Multicenter Phase II Study (26952) of the European Organization for Research and
Treatment of Cancer
Brain Tumor Group
Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have discovered a peripheral biomarker in human blood serum that can be used to detect the presence and progress of glioblastoma
brain tumors before and after
treatment.
School of Allied Health Sciences» Steen Madsen is exploring new
treatment methods for primary
brain tumors —
tumors that originate in the
brain — using nanoparticles and lasers.
Personalizing
treatment for
brain tumors based on an individual's ATRX mutation status is still a concept, not a reality.
Biomarker Combos May Hold Key to Anti-PD-1 / PD - L1 Therapy Response OncLive.com — July 26, 2016 Tanning Rates Among NJ Teens Remains Stable MyCentralJersey.com — July 25, 2016 Intervention May Help Kids who Beat
Brain Tumors Recover their Social Skills MedLinx.com — July 18, 2016 Fighting Prostate Cancer:
Treatments Evolve From Robotic Surgery to Hormonal Therapy NJ.com/Inside Jersey Magazine — June 16, 2016 Fighting Advanced Cancer with Immunotherapy ScienceDaily.com — June 2, 2016
Lifesaving
treatments for childhood
brain tumors are a double - edged sword.
Radiation may be the best
treatment for children with certain
brain tumors, but it can also leave patients stressed and anxious.